Lambert-Eaton myasthenic syndrome developing post-diagnosis of small-cell lung cancer.

Dean, Samantha; McCracken, James; Kosmider, Suzanne; Herath, Dishan

Dean, Samantha; McCracken, James; Kosmider, Suzanne; Herath, Dishan.

Affiliation

Dean S; Sunshine Hospital, Western Health, Melbourne, Victoria, Australia.
McCracken J; Sunshine Hospital, Western Health, Melbourne, Victoria, Australia.
Kosmider S; Sunshine Hospital, Western Health, Melbourne, Victoria, Australia.
Herath D; Sunshine Hospital, Western Health, Melbourne, Victoria, Australia.

Intern Med J ; 48(12): 1541-1542, 2018 12.

Article in En | MEDLINE | ID: mdl-30518000

Subject(s)

Carboplatin/administration & dosage; Etoposide/administration & dosage; Lambert-Eaton Myasthenic Syndrome; Lung Neoplasms; Small Cell Lung Carcinoma; Aged; Antineoplastic Agents/administration & dosage; Diagnosis, Differential; Disease Progression; Humans; Lambert-Eaton Myasthenic Syndrome/diagnosis; Lambert-Eaton Myasthenic Syndrome/etiology; Lambert-Eaton Myasthenic Syndrome/physiopathology; Lung Neoplasms/complications; Lung Neoplasms/drug therapy; Lung Neoplasms/pathology; Male; Neoplasm Staging; Neurologic Examination/methods; Prognosis; Small Cell Lung Carcinoma/drug therapy; Small Cell Lung Carcinoma/pathology; Terminal Care/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lambert-Eaton Myasthenic Syndrome / Carboplatin / Etoposide / Small Cell Lung Carcinoma / Lung Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies Limits: Aged / Humans / Male Language: En Journal: Intern Med J Journal subject: MEDICINA INTERNA Year: 2018 Type: Article Affiliation country: Australia

Fulltext

XML

PubMed Links

Search on Google